Natera, Inc. (NTRA) co-founder Jonathan Sheena sells 9,150 shares
Rhea-AI Filing Summary
Natera, Inc. director and co-founder Jonathan Sheena reported open‑market sales of a total of 9,150 shares of common stock on August 7, 2026, at prices between $308.4000 and $320.9000 per share. These sales were effected under a Rule 10b5‑1 trading plan adopted on December 12, 2025. The filing also lists 18,032 shares held in each of Caraluna 1 Trust and Caraluna 2 Trust for the benefit of trust beneficiaries, and the reporting person disclaims beneficial ownership of those securities.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary 10b5-1
Net Seller: 9,150 shares
Net Sell
12 txns
Insider
Sheena Jonathan
Role
Director
Sold
9,150 shs ($2.89M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1 | 100 | $308.40 | $31K |
| Sale | Common Stock F1, F2 | 400 | $310.225 | $124K |
| Sale | Common Stock F1, F3 | 400 | $311.8788 | $125K |
| Sale | Common Stock F1, F4 | 900 | $313.0672 | $282K |
| Sale | Common Stock F1, F5 | 850 | $314.2517 | $267K |
| Sale | Common Stock F1, F6 | 600 | $315.3175 | $189K |
| Sale | Common Stock F1, F7 | 5,111 | $316.6118 | $1.62M |
| Sale | Common Stock F1, F8 | 200 | $317.965 | $64K |
| Sale | Common Stock F1 | 100 | $318.63 | $32K |
| Sale | Common Stock F1 | 489 | $320.90 | $157K |
| holding | Common Stock F9 | -- | -- | -- |
| holding | Common Stock F9 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 236,464 shares (Direct);
Common Stock — 18,032 shares (Indirect, By Caraluna 1 Trust);
Common Stock — 18,032 shares (Indirect, By Caraluna 2 Trust)
Footnotes (9)
- F1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
- F2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $309.9250 to $310.5250 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $311.5050 to $312.5000 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $312.5950 to $313.3150 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $313.9500 to $314.7150 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $315.04 to $315.67 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.10 to $316.78 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F8. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.62 to $318.31 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F9. Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Key Figures
Total shares sold: 9,150 shares
Lowest reported sale price: $308.4000 per share
Highest reported sale price: $320.9000 per share
+2 more
5 metrics
Total shares sold
9,150 shares
Aggregate common stock sales by Jonathan Sheena on August 7, 2026
Lowest reported sale price
$308.4000 per share
Per-share price for a 100-share sale of common stock on August 7, 2026
Highest reported sale price
$320.9000 per share
Per-share price for a 489-share sale of common stock on August 7, 2026
Caraluna 1 Trust holdings
18,032 shares
Indirect common stock holdings following the reported transactions, held for trust beneficiaries
Caraluna 2 Trust holdings
18,032 shares
Indirect common stock holdings following the reported transactions, held for trust beneficiaries
Key Terms
Rule 10b5-1 trading plan, weighted average price, beneficial ownership, open market or private transaction
4 terms
Rule 10b5-1 trading plan regulatory
"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The reported price in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficial ownership financial
"The Reporting Person disclaims beneficial ownership over such securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
open market or private transaction financial
"Sale in open market or private transaction"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Natera (NTRA) disclose for August 7, 2026?
Natera reported that director and co-founder Jonathan Sheena sold 9,150 shares of Natera common stock on August 7, 2026 in a series of open-market transactions executed under a Rule 10b5-1 trading plan adopted on December 12, 2025.
What indirect Natera (NTRA) holdings are associated with the Caraluna trusts?
The filing reports 18,032 shares of Natera common stock held indirectly by Caraluna 1 Trust and another 18,032 shares held by Caraluna 2 Trust. These shares are held for the benefit of trust beneficiaries, and the reporting person disclaims beneficial ownership.
What is Jonathan Sheena’s role at Natera (NTRA) according to the filing?
The reporting person, Jonathan Sheena, is identified as a director of Natera and is also described as a co-founder. This role information appears alongside his name in the reporting person section of the insider transaction disclosure.